LNLal Devayani Vasudevan Nair

Lal Devayani Vasudevan Nair

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lal Devayani Vasudevan Nair has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intrauterine Aluminium Exposure Due to Dietary Content Alters Social Behaviours in Wistar Rat Offsprings

    by Lal D.V. Nair, Senthilkumar Sivanesan, Devika S. Kumar

    Background: Neurodevelopmental disorders like autism are on the rise, with the role of genetics and epigenetics being increasingly cited as reasons or contributors. The environmental factors were found to be important as epigenetic modifiers, and pregnant mothers are incrementally exposed to many of these environmental factors, like aluminium (Al), known to damage neurons, even before delivery. However, its presence and persistence inside the central nervous system (CNS), leading to changes in the expression of behaviours, need further research. Hence, this animal study was conceived. Purpose: To evaluate the impact of early dietary exposure to Al in the brains of foetuses of pregnant rats and its subsequent effects on the neurobehaviour in their pups. Methods: Pregnant Wistar rats were divided into four groups (Gr1 receiving injection tetanus toxoid; Gr2 receiving tetanus toxoid + soy; Gr3 receiving tetanus toxoid + valproic acid and Gr4 receiving tetanus toxoid + soy + valproic acid). A few pups were sacrificed, and their brain Al and α-synuclein levels were assessed. Others were allowed to grow, and their behaviour, α-synuclein and Al levels were analysed. Results: α-synuclein was low in groups 3 and 4, with group 4 pups with abnormal socialisation behaviours exhibiting the lowest levels, suggesting ongoing neuronal injury. Brain Al in pups sacrificed immediately after birth suggests prenatal Al exposure, with the highest values in group 4, though all had elevated Al levels. Gr4 had impaired socialisation. Higher sociability indices were noted in groups 1 and 2 (0.36 and 0.3) compared to groups 3 and 4 (0.09 and 0.04). Groups 1 and 2 pups demonstrated intact social memory and novelty seeking. There was also a negative correlation between brain Al and α-synuclein levels and the socialisation index. Conclusion: Environmental factors like Al once enter the CNS remain in the brain even when invisible in blood and can induce changes in the growing brain, behaviour and socialisation.

  • Impact of Developmental Pediatrics-Based Training for Primary School Teachers in Early Identification of Learning Disability

    by Samir Dalwai, Jeeson C. Unni, Zafar Meenai, Kawaljit S. Multani, Nisha Boopathy, Leena Srivastava, Shambhavi Seth, Lal D. V. Nair, Arul Devi, Deborahl Aaron

    The increasing survival of high-risk newborns has led to an increase in neurodevelopmental and learning problems in children. With preschools largely remaining unregulated, primary school teachers with a basic degree and diploma/bachelor’s degree in education as minimum requirement in India, may lack training, especially to suspect medical issues contributing to learning difficulties. This study assessed the feasibility of a country-level application under the aegis of the Indian Academy of Pediatrics. A pre-experimental, one-group time series study done with primary school teachers, trained on poor scholastic performance training using a module with case discussions on identifying and assessing school failure, investigations, management options, educational support, and advocacy. Pre-test/post-test and long-term impact increased awareness that educational difficulties could be caused/exacerbated by medical issues. Effectiveness persisted over time in identifying behavioral changes in these children. This module is a cost-effective, feasible alternative for programs lacking access to live expert content.


  • Obesity with developmental delay in infancy: a rare cause not to miss—pseudohypoparathyroidism

    by Anees F M Ahmed, Rine Benson Thobias, Nilavan Thirumavalavan, Santhosh Thangamani, Lal D V Nair

    Mild developmental delay in infants with obesity is often disregarded, attributing it to increased weight by parents and practitioners. We report an infant with obesity and gross motor delay after the first 6 months of age, seizures and obstructive sleep apnoea. The child was diagnosed with pseudohypoparathyroidism (PHP) and was medically managed with parenteral calcium, vitamin D and magnesium. Appropriate early interventions by developmental therapists addressing the developmental domains coordinated by developmental paediatricians and relevant drug and diet management corrected the delay. The child is followed up for soft tissue calcifications, kidney functions and skeletal health. This case highlights the importance of early recognition and comprehensive management of correctable conditions like PHP by developmental specialists rather than addressing only the developmental aspect of it.

  • Open Access

    Synucleins As Biomarkers of Severity in Autism Spectrum Disorder

    by Lal D. V. Nair, Senthil Kumar Sivanesan, Devika S. Kumar

    Introduction Autism spectrum disorder (ASD) is a lifelong disorder affecting children quite early in life, manifested as delays in communication and stereotypic behaviors. To date, it is diagnosed clinically using the Diagnostic and Statistical Manual-5 (DSM-V) criteria due to the lack of biomarkers that can specifically denote the disorder. The role of synucleins in this context has been considered due to the increasing evidence of neurodegeneration in many autistic children. Synucleins are a group of soluble neuronal proteins primarily expressed in the central nervous system. They are of three types: α-, β-, and ɣ-synuclein. α-synuclein is involved in vesicle trafficking and release of neurotransmitters. There is no uniformity in the scientific community regarding their levels of autism, with few studies showing increasing levels and others to the contrary. Hence, the present study was conceived to analyze the levels of α-synuclein and β-synuclein in autistic children and to correlate with the disease severity. Objectives The main objective of the study was to assess the levels of α- and β-synuclein in autistic children of 2-8 years of age and to identify the correlation between the severity of core symptoms of autism and α- and β-synuclein levels. It is intended to assess the possibility of using α- and β-synuclein/their ratio as a biomarker of the severity of autism. Materials and methods Plasma levels of α-synuclein and β-synuclein were measured in 160 ASD children and 40 healthy age and sex-matched children by ELISA. Their symptom severity was assessed with CARS-2 ST and the Indian Scale of Autism Assessment (ISAA). Values of α- and β-synuclein were analyzed for correlation with the severity rating of ASD. Cut-off values of α-synuclein and β-synuclein that discriminate the presence of autism and its severity were assessed using Jamovi 2.4.14 software. Results The results show that α-synuclein levels were significantly reduced (5.02 ± 0.586; range: 3.13-6.0 ng/ml) when compared with healthy controls (29.47 ± 18.62 ng/ml; range: 22.39- 36.56) with p < 0.001, and β-synuclein levels were elevated (1424 ng/ml ± 122; range: 1229-1616 ng/ml) when compared to control, though not significantly. Plasma levels of α-synuclein significantly correlate with disease severity with good diagnostic accuracy (86%), but β-synuclein levels did not correlate with severity. The fold changes of synucleins, especially the fold decrease in levels of α-synuclein, were discriminative for the diagnosis and severity with good sensitivity (93.6%), specificity (74.3%), positive predictive (92.6%), and negative predictive values (76.5%). The fold increase in β-synuclein did not have any significance in predicting the severity of autism. Conclusion The present study showed that α-synuclein and β-synuclein were associated with ASD and can be used to assess its severity. A fold decrease in α-synuclein was found to have good discriminating value in differentiating the severity of autism. It may be of use especially in mild and high-functioning autism, when clinically distinguishing them may be difficult.


  • Open Access

    Extracellular Oxidative Stress Markers in COVID-19 Patients with Diabetes as Co-Morbidity

    by Devika Sanil Kumar, Gowtham Hanumanram, Prasanna Karthik Suthakaran, Jagadeesan Mohanan, Lal Devayani Vasudevan Nair, Kannan Rajendran

    COVID-19 patients have a higher risk of developing inflammatory responses associated with serious and even fatal respiratory diseases. The role of oxidative stress in exacerbating manifestations in COVID-19 pathogenesis is under-reported.This study aimed touseserum levels of superoxide dismutase (SOD3) and glutathione-S-transferase (GSTp1) by ELISA, zinc (ErbaChem5), ferritin and free iron (VitrosChemistry, Ortho Clinical Diagnosis, Raritan, NJ, USA) at the first encounter of randomly selected RT-PCR-positive COVID-19 patients, for assessing disease severity. The parameters which helped in identifying the severity, leading to poor prognosis, were neutrophil:lymphocyte higher than 4, high CRP, low SOD3 values and high GSTp1 values, and diabetes mellitus as a co-morbidity. Higher zinc levels correlated with high GSTp1 and low SOD3, indicating the protective effect of zinc on ROS. The increased high GSTp1 shows an anticipated protective biochemical response, to mitigate the low SOD3 values due to ROS consumption. Decreased SOD3 levels indicate a state of high oxidative stress at cellular levels, and an anticipated increase in GSTp1 levels points to the pathophysiological bases of increasing severity with age, sex, and co-morbidities, such asdiabetes. High levels of initial GSTp1 and zinc levels possibly offer protection to redox reactions at the cellular level in severe COVID-19 infection, preventing deterioration.


  • Epilepsy in KCNH1‐related syndromes

    by Mario Mastrangelo, Ingrid E. Scheffer, Nuria C. Bramswig, Lal. D.V. Nair, Candace T. Myers, Maria Lisa Dentici, Georg C. Korenke, Kelly Schoch, Philippe M. Campeau, Susan M. White, et al.

    Aim. KCNH1 mutations have been identified in patients with Zimmermann‐Laband syndrome and Temple‐Baraitser syndrome, as well as patients with uncharacterized syndromes with intellectual disability and overlapping features. These syndromes include dysmorphic facial features, nail hypo/aplasia, thumb and skeletal anomalies, intellectual disability, and seizures. We report the epilepsy phenotype in patients with KCNH1 mutations.Methods. Demographic data, electroclinical features, response to antiepileptic drugs, and results of significant diagnostic investigations of nine patients carrying mutations in KCNH1 were obtained from referring centres.Results. Epilepsy was present in 7/9 patients. Both generalized and focal tonic‐clonic seizures were observed. Complete seizure control was achieved with pharmacological treatment in 2/7 patients; polytherapy was required in 4/7 patients. Status epilepticus occurred in 4/7 patients. EEG showed a diffusely slow background in 7/7 patients with epilepsy, with variable epileptiform abnormalities. Cerebral folate deficiency and an increase in urinary hypoxanthine and uridine were observed in one patient.Conclusions. Epilepsy is a key phenotypic feature in most individuals with KCNH1‐related syndromes, suggesting a direct role of KCNH1 in epileptogenesis, although the underlying mechanism is not understood.


  • Open Access

    Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome

    by Fanny Kortüm, Viviana Caputo, Christiane K Bauer, Lorenzo Stella, Andrea Ciolfi, Malik Alawi, Gianfranco Bocchinfuso, Elisabetta Flex, Stefano Paolacci, Maria Lisa Dentici, et al.

    Zimmermann-Laband syndrome (ZLS) is a developmental disorder characterized by facial dysmorphism with gingival enlargement, intellectual disability, hypoplasia or aplasia of nails and terminal phalanges, and hypertrichosis. We report that heterozygous missense mutations in KCNH1 account for a considerable proportion of ZLS. KCNH1 encodes the voltage-gated K(+) channel Eag1 (Kv10.1). Patch-clamp recordings showed strong negative shifts in voltage-dependent activation for all but one KCNH1 channel mutant (Gly469Arg). Coexpression of Gly469Arg with wild-type KCNH1 resulted in heterotetrameric channels with reduced conductance at positive potentials but pronounced conductance at negative potentials. These data support a gain-of-function effect for all ZLS-associated KCNH1 mutants. We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H(+) ATPase, in two individuals with ZLS. Structural analysis predicts a perturbing effect of the mutation on complex assembly. Our findings demonstrate that KCNH1 mutations cause ZLS and document genetic heterogeneity for this disorder.


  • Open Access

    Absence of Nails, Deaf-mutism, Seizures, and Intellectual Disability: A Case Report

    by Lal DevayaniVasudevan Nair

    Seizures coexists in children with intellectual disability and are often attributed to neural dysfunction associated with it. Often a careful clinical examination will unravel many diagnostic pointers as in this 8-year-old child with global development delay, deaf-mutism and moderate intellectual disability (mental retardation) who presented with seizures in the emergency department. General examination revealed dysmorphic features like anonychia, low set ears, long philtrum, large lower lips and abnormal dermatoglyphics with features of osteodystrophy on radiology. She was diagnosed as a case of DOORS syndrome, an extremely rare genetic condition affecting the TCA cycle, with just over 40 cases reported, worldwide till date, since its first description in 1961. Her genetic analysis did not reveal the common TBC1D24 mutation in 16p13.3 resulting often from substitutions affecting the arginine at position 242, in spite of all classical clinical features associated with it, suggesting genetic heterogeneity in DOORS syndrome. Though four year follow-up revealed changes in seizure pattern, there was no optic atrophy, change in IQ or peripheral nerve problem. This probably suggests that children with typical clinical features and TBC1D24 mutations may have more progressive deterioration than those without it and newer molecular techniques may identify unexplained phenotypic expressions.


  • Open Access

    Incontinence in Intellectual Disability: An Under Recognized Cause

    by Lal Devayani Vasudevan Nair

    Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.


  • Open Access

    The genetic basis of DOORS syndrome: an exome-sequencing study

    by Philippe M Campeau, Dalia Kasperaviciute, James T Lu, Lindsay C Burrage, Choel Kim, Mutsuki Hori, Berkley R Powell, Fiona Stewart, Têmis Maria Félix, Jenneke van Den Ende, et al.